Form 4: Nlight CEO Scott Keeney Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Nlight's CEO, Scott Keeney, exercised stock options and sold 30,000 shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- Scott Keeney, the President and CEO of Nlight, Inc., executed stock options to acquire 30,000 shares of common stock at a price of $0.75 per share.
- Concurrently, Keeney sold 30,000 shares of Nlight common stock on October 17 and 18, 2024, at weighted average prices of $11.20 and $11.08, respectively.
- These transactions were conducted under a Rule 10b5-1 trading plan.
- Following these transactions, Keeney still beneficially owns 1,347,781 shares of Nlight common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction under a pre-existing plan. The CEO is exercising options and selling shares, which is neither overtly positive nor negative.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects. The use of 10b5-1 plans allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The exercise and sale of shares by executives are typical, especially when part of a pre-planned trading strategy like a 10b5-1 plan.
- Comparable companies such as Coherent, IPG Photonics, and Lumentum also see regular Form 4 filings related to executive stock transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The CEO's continued ownership of a significant number of shares suggests ongoing alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 02/26/2016 | Date stock option grant became fully vested and exercisable |
| 10/17/2024 | Date of stock option exercise and sale of 15,000 shares |
| 10/18/2024 | Date of stock option exercise and sale of 15,000 shares |
| 10/21/2024 | Date of Form 4 filing |
| 02/26/2025 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.